Projects per year
A Phase 1 Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of Single and Multiple Doses of ABI-H2158 in Healthy Volunteers; and the Multiple-Ascending Dose Pharmacokinetics and Pharmacodynamics in Patients with Chronic Hepatitis B Infection.
Roberts, S. & Mitchell, J. L.
29/05/19 → 30/09/19
An Open-Label Study to Assess The Efficacy and Safety of LM011 In Subjects Diagnosed With Non-Alcoholic Steatohepatitis (NASH).
16/04/19 → 31/12/19
Comparison of Regional Transit Measurement for the Atmo Capsule with those of a Gold Standard (Smart Pill)
13/03/19 → 1/06/20
The impact of day-time and night-time endurance exercise on gastrointestinal integrity, functional responses, symptoms, and systemic endotoxin and cytokine profiles - A laboratory controlled mechanistic exploration of circadian variation influences in ultra-endurance athletes.
4/02/19 → 31/12/19
A Phase 2 Randomized, Double-blind, Placebo-controlled Study in HLA-DQ2.5+ Adults With Celiac Disease to Assess the Effect of Nexvax2 on Symptoms After Masked Gluten Food Challenge.
Brown, G. & Secomb, R.
5/11/18 → 31/12/19
Comparison of the performance of SB2‐Infliximab with originator Infliximab in the measurement of concentrations in serum
23/05/18 → 23/06/18
1/07/17 → 30/06/18
Community Approach Targeting Cirrhosis and Hepatocellular carcinoma (CATCH) in patients living with chronic viral hepatitis
17/04/17 → 16/04/19
1/01/14 → 31/12/16